Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPACE BIOSCIENCES, INC.IDXG · Entity 7296 | Chief Financial Officer | January 29, 2020 | February 04, 2020 |
| Profusa, Inc.PFSA · Entity 2740 | Chief Financial Officer | August 21, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPACE BIOSCIENCES, INC.
Report date January 29, 2020 · Filed February 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.91 · Expires 2030-01-29 | Direct | 60,000 |
Reported balance
After 2020-01-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-29 · Grant · Acquired 60,000 · Balance 60,000 F1: The stock option is eligible to vest in equal installments on each of the first three anniversaries of the date of grant, subject to the continued employment with the Issuer through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option is eligible to vest in equal installments on each of the first three anniversaries of the date of grant, subject to the continued employment with the Issuer through the applicable vesting dates.
Profusa, Inc.
Report date August 21, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,470 |
Reported balance
After 2026-08-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-21 · Other · Acquired 54,323 · Balance 54,470 F1: Pro rata distribution from NorthView Sponsor I LLC, of which the reporting person is a manager. F2: Includes 147 shares held directly by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectBy NorthView Sponsor I LLC | 0 |
Reported balance
After 2026-08-21 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-21 · Other · Disposed 301,991 · Balance 0 F3: On August 21, 2026, NorthView Sponsor I LLC distributed all its shares of Issuer's common stock to its members, including 54,323 shares to the reporting person. F4: Fred Knechtel is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pro rata distribution from NorthView Sponsor I LLC, of which the reporting person is a manager.
F2: Includes 147 shares held directly by the reporting person.
F3: On August 21, 2026, NorthView Sponsor I LLC distributed all its shares of Issuer's common stock to its members, including 54,323 shares to the reporting person.
F4: Fred Knechtel is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2026 Filed Sep 4, 2026 14:48 UTC | Profusa, Inc. PFSA · Entity 2740 | OtherCommon Stock | 301,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-097491 · ownership.xml · nonDerivative · entry 2 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By NorthView Sponsor I LLC Disclosed balance after: 0 F3 · balance_after: On August 21, 2026, NorthView Sponsor I LLC distributed all its shares of Issuer's common stock to its members, including 54,323 shares to the reporting person. F4 · ownership.nature: Fred Knechtel is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 21, 2026 Filed Sep 4, 2026 14:48 UTC | Profusa, Inc. PFSA · Entity 2740 | OtherCommon Stock | 54,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-097491 · ownership.xml · nonDerivative · entry 1 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,470 F1 · shares: Pro rata distribution from NorthView Sponsor I LLC, of which the reporting person is a manager. F2 · balance_after: Includes 147 shares held directly by the reporting person. Read SEC document |
| August 12, 2026 Filed Aug 20, 2026 00:15 UTC | Profusa, Inc. PFSA · Entity 2740 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $4.28 | $1,292,521.00 |
DisclosureSEC source: 0001213900-26-091841 · ownership.xml · derivative · entry 3 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By NorthView Sponsor I LLC Disclosed balance after: Not disclosed Underlying: Common Stock · 301,991 shares Expires 2026-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The conversion price is equal to the higher of (i) $1.07 and (ii) the closing price of the Common Stock on the trading day immediately preceding the delivery of the Conversion Notice, as reported on The Nasdaq Stock Market, pursuant to Amendment No. 3 to the Note Modification and Conversion Agreement dated August 12, 2026. The pre-split conversion price of $1.07 per share is equivalent to $4.28 per share on a post-split basis following the 1-for-4 reverse stock split. F4 · reported_value: Represents the conversion of $1,292,521 principal amount of the Convertible Promissory Note into 1,207,964 shares of Common Stock (301,991 shares on a post-split basis), reflecting conversion at the $1.07 per share ($4.28 per share on a post-split basis) price pursuant to the Conversion Notice dated August 12, 2026. F5 · derivative.exercise_date: The Note became convertible on May 4, 2026 (the Registration Effective Date), pursuant to Section 2.1 of the Note Modification and Conversion Agreement dated April 24, 2026. F1 · derivative.underlying_shares: On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991. F6 · valueOwnedAfter: Represents the remaining principal balance of the Note following conversion. F3 · ownership.nature: Fred Knechtel is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 12, 2026 Filed Aug 20, 2026 00:15 UTC | Profusa, Inc. PFSA · Entity 2740 | ConversionCommon Stock | 301,991 | $4.28 | $1,292,521.48 |
DisclosureSEC source: 0001213900-26-091841 · ownership.xml · nonDerivative · entry 1 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By NorthView Sponsor I LLC Disclosed balance after: 301,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991. F2 · price: The conversion price is equal to the higher of (i) $1.07 and (ii) the closing price of the Common Stock on the trading day immediately preceding the delivery of the Conversion Notice, as reported on The Nasdaq Stock Market, pursuant to Amendment No. 3 to the Note Modification and Conversion Agreement dated August 12, 2026. The pre-split conversion price of $1.07 per share is equivalent to $4.28 per share on a post-split basis following the 1-for-4 reverse stock split. F1 · balance_after: On August 12, 2026, 1,207,964 shares of Common Stock were issued upon conversion of a portion of the Convertible Promissory Note. Following a 1-for-4 reverse stock split effected after the conversion, the number of shares held became 301,991. F3 · ownership.nature: Fred Knechtel is a manager of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| May 04, 2026 Filed May 6, 2026 01:24 UTC | Profusa, Inc. PFSA · Entity 2740 | PurchaseConvertible Promissory Note · Derivative | Not disclosed | $1,869,796.00 Strike: $0.35 | $1,869,796.00 |
DisclosureSEC source: 0001213900-26-052488 · ownership.xml · derivative · entry 1 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By NorthView Sponsor I LLC Disclosed balance after: Not disclosed Underlying: Common Stock · 5,342,274 shares Expires 2026-12-31 F1 · derivative.exercise_price: The conversion price is equal to the greater of (i) 95% of the closing price of the Common Stock on the Conversion Date and (ii) $0.35 per share, pursuant to the Note Modification and Conversion Agreement dated April 24, 2026. F2 · derivative.exercise_date: The Note became exercisable (convertible) on the Registration Effective Date, pursuant to Section 2.1 of the Note Modification and Conversion Agreement dated April 24, 2026. F3 · derivative.underlying_shares: Represents the conversion of the entire outstanding principal balance of the Second Amended and Restated Promissory Note, dated April 6, 2026, in the amount of $1,869,796 into 5,342,274 shares of Common Stock, reflecting conversion at the $0.35 per share floor price. F4 · ownership.nature: Mr. Knechtel is the managing member of NorthView Sponsor I LLC and may be deemed to share beneficial ownership of the securities held by NorthView Sponsor I LLC. Mr. Knechtel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 26, 2026 Filed Feb 2, 2026 11:40 UTC | Profusa, Inc. PFSA · Entity 2740 | OtherWarrants · Derivative | 516,863 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001213900-26-010524 · ownership.xml · derivative · entry 2 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,863 Underlying: Common Stock · 516,863 shares Expires 2030-07-11 F1 · kind: Represents the distribution for no consideration by NorthView Sponsor I LLC (the "Sponsor") to the Reporting Person of (i) 818,961 shares of Common Stock, and (ii) 516,863 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members. Read SEC document |
| January 26, 2026 Filed Feb 2, 2026 11:40 UTC | Profusa, Inc. PFSA · Entity 2740 | OtherCommon Stock | 818,961 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-010524 · ownership.xml · nonDerivative · entry 1 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 818,961 F1 · kind: Represents the distribution for no consideration by NorthView Sponsor I LLC (the "Sponsor") to the Reporting Person of (i) 818,961 shares of Common Stock, and (ii) 516,863 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members. F1 · price: Represents the distribution for no consideration by NorthView Sponsor I LLC (the "Sponsor") to the Reporting Person of (i) 818,961 shares of Common Stock, and (ii) 516,863 warrants to purchase shares of Common Stock, in connection with a pro rata distribution of Issuer securities held by the Sponsor to its members. Read SEC document |
| January 29, 2020 Filed Feb 4, 2020 00:24 UTC | INTERPACE BIOSCIENCES, INC. IDXG · Entity 7296 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $7.91 | $0.00 |
DisclosureSEC source: 0001493152-20-001534 · ownership.xml · derivative · entry 1 Knechtel Fred S. · CIK 0001564260 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-01-29 F1 · derivative.exercise_date: The stock option is eligible to vest in equal installments on each of the first three anniversaries of the date of grant, subject to the continued employment with the Issuer through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.